Anti-Human CD30/TNFRSF8 Reference Antibody (HeFi-1, RUO) (HB038056)

价格:

规格：

100ug
1mg
5mg
10mg
25mg
50mg
100mg

数量：

一键复制产品信息

概述
图片
参考文献
产品说明书

货号	HB038056
品牌	abinScience
种属反应性	Human
应用	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
宿主	Human
同种型	IgG
克隆号	HeFi-1
生物活性	HeFi-1 (0.1 ng/uL, 1 h) can bind specifically to Karpas299 cells with a binding rate of over 90 % [1]. HeFi-1 (20 ug/mL, 48 h) can significantly inhibit the proliferation of Karpas299 cells and induces G1 phase blockade [1]. HeFi-1 (20 ug/mL, 12-24 h) can significantly induce apoptosis in eosinophil [2]. Cell Proliferation Assay [1] Cell Line: Karpas299 cells Concentration: 20 ug/mL Incubation Time: 48 h Result: Significantly inhibited cell proliferation with an inhibition rate of 40%, superior to Daclizumab (). Cell Cycle Analysis [1] Cell Line: Karpas299 cells Concentration: 20 ug/mL Incubation Time: 48 h Result: Induced G1 phase arrest and a decrease in S phase cells. HeFi-1 (100 ug, i.v., once weekly, for 4 weeks) can effectively prolong survival in SCID/NOD wild-type and FcRγ -/- mice bearing Karpas299 lymphoma [1].
表达系统	Mammalian cells
克隆类型	Monoclonal
靶标	CD30L receptor, Ki-1 antigen, CD30, TNFRSF8, D1S166E, Tumor necrosis factor receptor superfamily member 8, Lymphocyte activation antigen CD30
内毒素水平	< 10 EU/mg
纯度	>95% purity as determined by SDS-PAGE.
纯化方式	Protein A/G purified from cell culture supernatant.
Accession号	P28908
状态	Liquid
保存溶液	0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
稳定性和存储	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
别名	HeFi-1, HeFi1, HeFi1
背景	Tumor necrosis factor receptor superfamily member 8 (CD30/TNFRSF8) is a ~63 kDa protein. Receptor for TNFSF8/CD30L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa-B. CD30 is the therapeutic target of brentuximab vedotin (Adcetris). 1. Smith, CA. et al. (1993) Cell 73, 1349-60. PMID: 8391931 2. Aizawa, S. et al. (1997) The Journal of biological chemistry 272, 2042-5. PMID: 8999898
文献	1. Zhang M, et al. Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors. Blood. 2006 Jul 15;108(2):705-10. [HB038056] 2. Berro AI, et al. Increased expression and activation of CD30 induce apoptosis in human blood eosinophils. J Immunol. 2004 Aug 1;173(3):2174-83. [HB038056]
Note	For research use only. Not suitable for clinical or therapeutic use.

SDS-PAGE

SDS-PAGE for Research Grade Anti-Human CD30/TNFRSF8 (HeFi-1)

产品说明书

Anti-Human CD30/TNFRSF8 Reference Antibody (HeFi-1, RUO).pdf

质量 (g) = 浓度 (mol/L) × 体积 (L) × 分子量 (g/mol)

填写 质量、浓度、体积中的任意 2 项 + 分子量，自动计算未知值。

分子量 *

g/mol

C₁ × V₁ = C₂ × V₂

填写 4 项中的任意 3 项，自动计算未知值。

C₁ (起始浓度)

V₁ (起始体积)

C₂ (终浓度)

V₂ (终体积)

重组蛋白

抗体

试剂盒

实验相关试剂

Anti-Human CD30/TNFRSF8 Reference Antibody (HeFi-1, RUO) (HB038056)

概述

图片

参考文献

产品说明书

相关产品推荐

重组蛋白

抗体

试剂盒

实验相关试剂

Anti-Human CD30/TNFRSF8 Reference Antibody (HeFi-1, RUO) (HB038056)

概述

图片

参考文献

产品说明书

相关产品推荐

获取报价